<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"
    xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:spotify="http://www.spotify.com/ns/rss">
    <channel>
        <title>BSG From Top to Bottom</title>
        <generator>Castos</generator>
        <atom:link href="https://feeds.castos.com/159q7" rel="self" type="application/rss+xml" />
        <link>https://bsg-fromtoptobottom.castos.com</link>
        <description>British Society of Gastroenterology&#039;s podcast, From Top to Bottom, gives you all the latest insights shaping modern gastroenterology practice from inspirational interviews to guideline summaries from leading experts.
Whether you&#039;re a gastroenterologist, trainee, or other healthcare professional seeking practical, evidence based updates — this podcast keeps you current from top to bottom.</description>
        <lastBuildDate>Fri, 27 Mar 2026 09:55:21 +0000</lastBuildDate>
        <language>en</language>
        <copyright>© 2025</copyright>
        
        <spotify:limit recentCount="100" />
        
        <spotify:countryOfOrigin>
              
        </spotify:countryOfOrigin>
                    <image>
                <url>https://episodes.castos.com/6841bf13d4fc03-86689111/images/1400.png</url>
                <title>BSG From Top to Bottom</title>
                <link>https://bsg-fromtoptobottom.castos.com</link>
            </image>
                <itunes:subtitle>British Society of Gastroenterology&#039;s podcast, From Top to Bottom, gives you all the latest insights shaping modern gastroenterology practice from inspirational interviews to guideline summaries from leading experts.
Whether you&#039;re a gastroenterologist, trainee, or other healthcare professional seeking practical, evidence based updates — this podcast keeps you current from top to bottom.</itunes:subtitle>
        <itunes:author>British Society of Gastroenterology</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:summary>British Society of Gastroenterology&#039;s podcast, From Top to Bottom, gives you all the latest insights shaping modern gastroenterology practice from inspirational interviews to guideline summaries from leading experts.
Whether you&#039;re a gastroenterologist, trainee, or other healthcare professional seeking practical, evidence based updates — this podcast keeps you current from top to bottom.</itunes:summary>
        <itunes:owner>
            <itunes:name>BSG</itunes:name>
            <itunes:email>mcroll@bsg.org.uk</itunes:email>
        </itunes:owner>
        <itunes:explicit>false</itunes:explicit>
                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/1400.png"></itunes:image>
        
                                    <itunes:category text="Education" />
                                                <itunes:category text="Health &amp; Fitness">
                                            <itunes:category text="Medicine" />
                                    </itunes:category>
                                                <itunes:category text="Science" />
                    
                    <itunes:new-feed-url>https://feeds.castos.com/159q7</itunes:new-feed-url>
                
        
        <podcast:locked>yes</podcast:locked>
                                    <item>
                <title>
                    <![CDATA[BSG IBD Surveillance Guidelines - part two]]>
                </title>
                <pubDate>Fri, 27 Mar 2026 09:55:21 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2406973</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/ibd-surveillance-guidelines-part-two</link>
                                <description>
                                            <![CDATA[<p>In this episode of the BSG Top to Bottom podcast, Prof James East and Prof Pradeep Bhandari dive into the endoscopic aspects of the new BSG IBD Surveillance Guidelines. Building on part one’s focus on cancer risk and surveillance rationale, this discussion explores practical essentials, from bowel preparation and patient comfort to chromoendoscopy, lesion detection, and the nuances of managing dysplasia in IBD. The conversation also highlights training, service delivery, MDT decision‑making, and the evolving roles of advanced endoscopic techniques and surgery. </p>
<h3>Chapters</h3>
<ul><li>(00:00:00) - Top to Bottom: Endoscopic Surveillance</li><li>(00:01:03) - The BSG Guidelines on IBD</li><li>(00:02:04) - IBD bowel prep</li><li>(00:06:01) - Colonoscopy: Comfort and Safety</li><li>(00:09:26) - BSG 5, Virtual Chromo Endoscopy</li><li>(00:18:24) - Invisible dysplasia</li><li>(00:21:09) - Who should be doing IBD endoscopy?</li><li>(00:25:06) - Diabetes and colitis 6, Neoplasia management</li><li>(00:34:11) - Segmental resection in IBD</li><li>(00:38:51) - Intensive surveillance for colonoscopy patients with dysplasia</li><li>(00:41:55) - Endoscopy and cancer: concordance</li></ul>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[In this episode of the BSG Top to Bottom podcast, Prof James East and Prof Pradeep Bhandari dive into the endoscopic aspects of the new BSG IBD Surveillance Guidelines. Building on part one’s focus on cancer risk and surveillance rationale, this discussion explores practical essentials, from bowel preparation and patient comfort to chromoendoscopy, lesion detection, and the nuances of managing dysplasia in IBD. The conversation also highlights training, service delivery, MDT decision‑making, and the evolving roles of advanced endoscopic techniques and surgery. ]]>
                </itunes:subtitle>
                                <itunes:title>
                    <![CDATA[BSG IBD Surveillance Guidelines - part two]]>
                </itunes:title>
                                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>In this episode of the BSG Top to Bottom podcast, Prof James East and Prof Pradeep Bhandari dive into the endoscopic aspects of the new BSG IBD Surveillance Guidelines. Building on part one’s focus on cancer risk and surveillance rationale, this discussion explores practical essentials, from bowel preparation and patient comfort to chromoendoscopy, lesion detection, and the nuances of managing dysplasia in IBD. The conversation also highlights training, service delivery, MDT decision‑making, and the evolving roles of advanced endoscopic techniques and surgery. </p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2406973/c1e-k6400cdgr67h941po-okp1v977t7wk-qxw6qs.mp3" length="41076480"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[In this episode of the BSG Top to Bottom podcast, Prof James East and Prof Pradeep Bhandari dive into the endoscopic aspects of the new BSG IBD Surveillance Guidelines. Building on part one’s focus on cancer risk and surveillance rationale, this discussion explores practical essentials, from bowel preparation and patient comfort to chromoendoscopy, lesion detection, and the nuances of managing dysplasia in IBD. The conversation also highlights training, service delivery, MDT decision‑making, and the evolving roles of advanced endoscopic techniques and surgery. ]]>
                </itunes:summary>
                                                                            <itunes:duration>00:42:47</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                                    <podcast:chapters url="https://media-assets.castos.com/chapters/2406973/chapter-data.json"
                        type="application/json" />
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Surveillance Guidelines - part 1]]>
                </title>
                <pubDate>Fri, 20 Mar 2026 11:41:39 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2401690</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/ibd-surveillance-guidelines-part-one</link>
                                <description>
                                            <![CDATA[<p>Join Dr. Shahida Din, consultant gastroenterologist and Chair of the BSG IBD Section, for an in‑depth conversation with Professor James East, leading gastroenterologist, endoscopist, and co‑author of the new BSG IBD Surveillance Guidelines. They explore how cancer risk in IBD has evolved, when to start or stop surveillance, and the shift toward personalised risk assessment. The episode covers key updates on bowel prep, biopsy strategies, patient experience, and what clinicians should know to deliver high quality, patient centred surveillance.<br /> Stay tuned for Part 2 on endoscopic techniques and dysplasia management with Professor Pradeep Bhandari </p>

<p></p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Join Dr. Shahida Din, consultant gastroenterologist and Chair of the BSG IBD Section, for an in‑depth conversation with Professor James East, leading gastroenterologist, endoscopist, and co‑author of the new BSG IBD Surveillance Guidelines. They explore how cancer risk in IBD has evolved, when to start or stop surveillance, and the shift toward personalised risk assessment. The episode covers key updates on bowel prep, biopsy strategies, patient experience, and what clinicians should know to deliver high quality, patient centred surveillance. Stay tuned for Part 2 on endoscopic techniques and dysplasia management with Professor Pradeep Bhandari 

]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Surveillance Guidelines - part 1]]>
                </itunes:title>
                                    <itunes:episode>11</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Join Dr. Shahida Din, consultant gastroenterologist and Chair of the BSG IBD Section, for an in‑depth conversation with Professor James East, leading gastroenterologist, endoscopist, and co‑author of the new BSG IBD Surveillance Guidelines. They explore how cancer risk in IBD has evolved, when to start or stop surveillance, and the shift toward personalised risk assessment. The episode covers key updates on bowel prep, biopsy strategies, patient experience, and what clinicians should know to deliver high quality, patient centred surveillance.<br /> Stay tuned for Part 2 on endoscopic techniques and dysplasia management with Professor Pradeep Bhandari </p>

<p></p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2401690/c1e-1jkmmbnjk1dfxv9gj-0v96d27nbdp-xktzpz.mp3" length="32715648"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Join Dr. Shahida Din, consultant gastroenterologist and Chair of the BSG IBD Section, for an in‑depth conversation with Professor James East, leading gastroenterologist, endoscopist, and co‑author of the new BSG IBD Surveillance Guidelines. They explore how cancer risk in IBD has evolved, when to start or stop surveillance, and the shift toward personalised risk assessment. The episode covers key updates on bowel prep, biopsy strategies, patient experience, and what clinicians should know to deliver high quality, patient centred surveillance. Stay tuned for Part 2 on endoscopic techniques and dysplasia management with Professor Pradeep Bhandari 

]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2401690/c1a-k6400-9jw650jwbo2n-yuiu8r.png"></itunes:image>
                                                                            <itunes:duration>00:34:04</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Post-op Crohn's Disease]]>
                </title>
                <pubDate>Fri, 19 Dec 2025 10:50:57 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2296957</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-post-op-cd</link>
                                <description>
                                            <![CDATA[<p>Part seven of seven: Dr Alexandra Kent, Consultant Gastroenterologist at King’s College Hospital, is joined by Professor Jimmy Limdi, Head of the IBD section at the Northern Care Alliance NHS Foundation Trust, to explore how Crohn's Disease recurrence is defined, predicted, monitored, and managed after surgery as recommended in the BSG IBD Guidelines.</p>
<p>Together, they discuss the continuum of post-operative recurrence from histological and endoscopic changes to clinical and surgical relapse. They highlight key patient, disease, and surgical risk factors, including smoking and aggressive disease phenotypes. The episode covers best practice for post-operative monitoring, including the role of ileocolonoscopy, Rutgeerts scoring, faecal calprotectin, intestinal ultrasound, and cross-sectional imaging.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part seven of seven: Dr Alexandra Kent, Consultant Gastroenterologist at King’s College Hospital, is joined by Professor Jimmy Limdi, Head of the IBD section at the Northern Care Alliance NHS Foundation Trust, to explore how Crohn's Disease recurrence is defined, predicted, monitored, and managed after surgery as recommended in the BSG IBD Guidelines.
Together, they discuss the continuum of post-operative recurrence from histological and endoscopic changes to clinical and surgical relapse. They highlight key patient, disease, and surgical risk factors, including smoking and aggressive disease phenotypes. The episode covers best practice for post-operative monitoring, including the role of ileocolonoscopy, Rutgeerts scoring, faecal calprotectin, intestinal ultrasound, and cross-sectional imaging.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Post-op Crohn's Disease]]>
                </itunes:title>
                                    <itunes:episode>10</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part seven of seven: Dr Alexandra Kent, Consultant Gastroenterologist at King’s College Hospital, is joined by Professor Jimmy Limdi, Head of the IBD section at the Northern Care Alliance NHS Foundation Trust, to explore how Crohn's Disease recurrence is defined, predicted, monitored, and managed after surgery as recommended in the BSG IBD Guidelines.</p>
<p>Together, they discuss the continuum of post-operative recurrence from histological and endoscopic changes to clinical and surgical relapse. They highlight key patient, disease, and surgical risk factors, including smoking and aggressive disease phenotypes. The episode covers best practice for post-operative monitoring, including the role of ileocolonoscopy, Rutgeerts scoring, faecal calprotectin, intestinal ultrasound, and cross-sectional imaging.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2296957/c1e-p64zzc1v0gdamo9p0-1p762dg2hv4-os6nfm.mp3" length="28486656"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part seven of seven: Dr Alexandra Kent, Consultant Gastroenterologist at King’s College Hospital, is joined by Professor Jimmy Limdi, Head of the IBD section at the Northern Care Alliance NHS Foundation Trust, to explore how Crohn's Disease recurrence is defined, predicted, monitored, and managed after surgery as recommended in the BSG IBD Guidelines.
Together, they discuss the continuum of post-operative recurrence from histological and endoscopic changes to clinical and surgical relapse. They highlight key patient, disease, and surgical risk factors, including smoking and aggressive disease phenotypes. The episode covers best practice for post-operative monitoring, including the role of ileocolonoscopy, Rutgeerts scoring, faecal calprotectin, intestinal ultrasound, and cross-sectional imaging.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2296957/c1a-k6400-gp9rjkqdawm8-i702ow.png"></itunes:image>
                                                                            <itunes:duration>00:29:40</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Luminal Crohn's Disease]]>
                </title>
                <pubDate>Fri, 12 Dec 2025 09:20:00 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2284449</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-luminal-crohns-disease</link>
                                <description>
                                            <![CDATA[<p>Part six of seven: Polychronis Pavlides, Consultant Gastroenterologist at King's College Hospital in London and Fraser Cummings, Consultant Gastroenterologist in Southampton and adult IBD service lead, discuss the first line treatment of Luminal Crohn’s Disease outlined in the newly updated BSG IBD Guidelines.</p>
<p>They explore the importance of shared decision making and patient centred care along with practical guidance on choosing therapies, monitoring response, and aligning with STRIDE targets. This podcast also includes the challenges in comparative effectiveness and why sequencing remains complex.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part six of seven: Polychronis Pavlides, Consultant Gastroenterologist at King's College Hospital in London and Fraser Cummings, Consultant Gastroenterologist in Southampton and adult IBD service lead, discuss the first line treatment of Luminal Crohn’s Disease outlined in the newly updated BSG IBD Guidelines.
They explore the importance of shared decision making and patient centred care along with practical guidance on choosing therapies, monitoring response, and aligning with STRIDE targets. This podcast also includes the challenges in comparative effectiveness and why sequencing remains complex.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Luminal Crohn's Disease]]>
                </itunes:title>
                                    <itunes:episode>9</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part six of seven: Polychronis Pavlides, Consultant Gastroenterologist at King's College Hospital in London and Fraser Cummings, Consultant Gastroenterologist in Southampton and adult IBD service lead, discuss the first line treatment of Luminal Crohn’s Disease outlined in the newly updated BSG IBD Guidelines.</p>
<p>They explore the importance of shared decision making and patient centred care along with practical guidance on choosing therapies, monitoring response, and aligning with STRIDE targets. This podcast also includes the challenges in comparative effectiveness and why sequencing remains complex.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2284449/c1e-0jknnbk4krqhgm3r5-mkwvwdjgammq-wmaxhe.mp3" length="25034496"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part six of seven: Polychronis Pavlides, Consultant Gastroenterologist at King's College Hospital in London and Fraser Cummings, Consultant Gastroenterologist in Southampton and adult IBD service lead, discuss the first line treatment of Luminal Crohn’s Disease outlined in the newly updated BSG IBD Guidelines.
They explore the importance of shared decision making and patient centred care along with practical guidance on choosing therapies, monitoring response, and aligning with STRIDE targets. This podcast also includes the challenges in comparative effectiveness and why sequencing remains complex.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2284449/c1a-k6400-z3pvvjn6u2d0-ps49md.png"></itunes:image>
                                                                            <itunes:duration>00:26:04</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Advanced Therapies in UC]]>
                </title>
                <pubDate>Fri, 05 Dec 2025 09:30:00 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2267374</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-advanced-therapies-in-uc</link>
                                <description>
                                            <![CDATA[<p>Part five of seven: Krishna Shah, Gastroenterology Registrar and IBD Research Fellow at the Royal London Hospital and Dr. Kamal Patel, Consultant Gastroenterologist at St George's Hospital discuss the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines beginning with mesalazine, prednisolone and azathioprine through to thiopurines and anti-TNFs. They discuss the cost-benefit outcomes of the drug pathways advised in the BSG Guidelines including some of the potential adverse side-effects.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part five of seven: Krishna Shah, Gastroenterology Registrar and IBD Research Fellow at the Royal London Hospital and Dr. Kamal Patel, Consultant Gastroenterologist at St George's Hospital discuss the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines beginning with mesalazine, prednisolone and azathioprine through to thiopurines and anti-TNFs. They discuss the cost-benefit outcomes of the drug pathways advised in the BSG Guidelines including some of the potential adverse side-effects.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Advanced Therapies in UC]]>
                </itunes:title>
                                    <itunes:episode>8</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part five of seven: Krishna Shah, Gastroenterology Registrar and IBD Research Fellow at the Royal London Hospital and Dr. Kamal Patel, Consultant Gastroenterologist at St George's Hospital discuss the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines beginning with mesalazine, prednisolone and azathioprine through to thiopurines and anti-TNFs. They discuss the cost-benefit outcomes of the drug pathways advised in the BSG Guidelines including some of the potential adverse side-effects.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2267374/c1e-2jn22bmgrw5i67j04-kpn6kow2u1vq-rigfch.mp3" length="70730496"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part five of seven: Krishna Shah, Gastroenterology Registrar and IBD Research Fellow at the Royal London Hospital and Dr. Kamal Patel, Consultant Gastroenterologist at St George's Hospital discuss the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines beginning with mesalazine, prednisolone and azathioprine through to thiopurines and anti-TNFs. They discuss the cost-benefit outcomes of the drug pathways advised in the BSG Guidelines including some of the potential adverse side-effects.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2267374/c1a-k6400-6zqjn811az7v-fbki7k.png"></itunes:image>
                                                                            <itunes:duration>01:13:40</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Perianal Crohn's Disease]]>
                </title>
                <pubDate>Fri, 28 Nov 2025 09:56:18 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2250962</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-perianal-cd</link>
                                <description>
                                            <![CDATA[<p>Part four of seven: Professor Naila Arebi, Consultant Gastroenterologist and colleague, Consultant Colorectal Surgeon, Janindra Warusavitarne, both at St Mark's National Bowel Hospital, discuss the application of the BSG IBD Guidelines to provide optimal treatment using a holistic approach and deliver the best quality of care for patients.</p>
<p>They talk about the important relationship between surgeons and gastroenterologists in the diagnosis and treatment of Perianal Crohn’s disease, supporting this with systematic clinical research.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part four of seven: Professor Naila Arebi, Consultant Gastroenterologist and colleague, Consultant Colorectal Surgeon, Janindra Warusavitarne, both at St Mark's National Bowel Hospital, discuss the application of the BSG IBD Guidelines to provide optimal treatment using a holistic approach and deliver the best quality of care for patients.
They talk about the important relationship between surgeons and gastroenterologists in the diagnosis and treatment of Perianal Crohn’s disease, supporting this with systematic clinical research.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Perianal Crohn's Disease]]>
                </itunes:title>
                                    <itunes:episode>7</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part four of seven: Professor Naila Arebi, Consultant Gastroenterologist and colleague, Consultant Colorectal Surgeon, Janindra Warusavitarne, both at St Mark's National Bowel Hospital, discuss the application of the BSG IBD Guidelines to provide optimal treatment using a holistic approach and deliver the best quality of care for patients.</p>
<p>They talk about the important relationship between surgeons and gastroenterologists in the diagnosis and treatment of Perianal Crohn’s disease, supporting this with systematic clinical research.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2250962/c1e-3jd11bko1zxbkq0j7-6zqr62d1t0z7-rwsvtq.mp3" length="14633088"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part four of seven: Professor Naila Arebi, Consultant Gastroenterologist and colleague, Consultant Colorectal Surgeon, Janindra Warusavitarne, both at St Mark's National Bowel Hospital, discuss the application of the BSG IBD Guidelines to provide optimal treatment using a holistic approach and deliver the best quality of care for patients.
They talk about the important relationship between surgeons and gastroenterologists in the diagnosis and treatment of Perianal Crohn’s disease, supporting this with systematic clinical research.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2250962/c1a-k6400-9j3m6o5qtqn3-aiqqg4.png"></itunes:image>
                                                                            <itunes:duration>00:15:14</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Acute Severe Ulcerative Colitis (ASUC)]]>
                </title>
                <pubDate>Fri, 21 Nov 2025 09:20:00 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2234457</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-acute-severe-ulcerative-colitis-asuc</link>
                                <description>
                                            <![CDATA[<p>Part three of seven: Trainee Gastroenterologist, Jennifer Tham, interviews, Dr. Bel Kok, Consultant Gastroenterologist at the Royal London Hospital and Honorary Senior Lecturer at Queen Mary University of London, to discuss the practical application of the latest ASUC guidelines. They explore the presenting symptoms and diagnosis of acute severe ulcerative colitis, including the use of statistical algorithms summarised in the IBD guidelines.</p>
<p>Given the severity and high risk profile of ASUC, rapid access to up-to-date guidance is essential to prevent delays in treatment. Jennifer and Dr. Kok also examine the updated therapies and management strategies outlined in the new guidelines.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part three of seven: Trainee Gastroenterologist, Jennifer Tham, interviews, Dr. Bel Kok, Consultant Gastroenterologist at the Royal London Hospital and Honorary Senior Lecturer at Queen Mary University of London, to discuss the practical application of the latest ASUC guidelines. They explore the presenting symptoms and diagnosis of acute severe ulcerative colitis, including the use of statistical algorithms summarised in the IBD guidelines.
Given the severity and high risk profile of ASUC, rapid access to up-to-date guidance is essential to prevent delays in treatment. Jennifer and Dr. Kok also examine the updated therapies and management strategies outlined in the new guidelines.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Acute Severe Ulcerative Colitis (ASUC)]]>
                </itunes:title>
                                    <itunes:episode>6</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part three of seven: Trainee Gastroenterologist, Jennifer Tham, interviews, Dr. Bel Kok, Consultant Gastroenterologist at the Royal London Hospital and Honorary Senior Lecturer at Queen Mary University of London, to discuss the practical application of the latest ASUC guidelines. They explore the presenting symptoms and diagnosis of acute severe ulcerative colitis, including the use of statistical algorithms summarised in the IBD guidelines.</p>
<p>Given the severity and high risk profile of ASUC, rapid access to up-to-date guidance is essential to prevent delays in treatment. Jennifer and Dr. Kok also examine the updated therapies and management strategies outlined in the new guidelines.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2234457/c1e-g63oocm5om7i249nq-pkvm30o9s9mo-3hr10d.mp3" length="14853120"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part three of seven: Trainee Gastroenterologist, Jennifer Tham, interviews, Dr. Bel Kok, Consultant Gastroenterologist at the Royal London Hospital and Honorary Senior Lecturer at Queen Mary University of London, to discuss the practical application of the latest ASUC guidelines. They explore the presenting symptoms and diagnosis of acute severe ulcerative colitis, including the use of statistical algorithms summarised in the IBD guidelines.
Given the severity and high risk profile of ASUC, rapid access to up-to-date guidance is essential to prevent delays in treatment. Jennifer and Dr. Kok also examine the updated therapies and management strategies outlined in the new guidelines.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2234457/c1a-k6400-8dov24j3argm-wkdxvq.png"></itunes:image>
                                                                            <itunes:duration>00:15:28</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - De-escalation of Therapy]]>
                </title>
                <pubDate>Fri, 14 Nov 2025 09:38:22 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2210159</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-de-escalation-of-therapy</link>
                                <description>
                                            <![CDATA[<p>Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.</p>
<p>They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.
They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - De-escalation of Therapy]]>
                </itunes:title>
                                    <itunes:episode>5</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.</p>
<p>They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2210159/c1e-7j3ppb96jgds292oo-1p7o5244c5xz-m3xzkn.mp3" length="94650048"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.
They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2210159/c1a-k6400-wwpj8464f7q5-onfala.png"></itunes:image>
                                                                            <itunes:duration>01:05:43</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG IBD Guideline - Methodology]]>
                </title>
                <pubDate>Fri, 07 Nov 2025 15:29:52 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2200105</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-ibd-guideline-methodology</link>
                                <description>
                                            <![CDATA[<p>Part one of a seven part series discussing different elements of the BSG IBD in Adults Guideline published in June 2025.</p>
<p>Prof. Gordon Moran from the University of Nottingham and Prof. Morris Gordon from the University of Central Lancashire (UCLan) discuss the new BSG IBD Guidelines published in GUT, June 2025. In particular, they discuss insight on methodology used to produce the guideline, the difference in previous guidelines (e.g. ECCO Guideline) and the use of network meta-anaysis.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Part one of a seven part series discussing different elements of the BSG IBD in Adults Guideline published in June 2025.
Prof. Gordon Moran from the University of Nottingham and Prof. Morris Gordon from the University of Central Lancashire (UCLan) discuss the new BSG IBD Guidelines published in GUT, June 2025. In particular, they discuss insight on methodology used to produce the guideline, the difference in previous guidelines (e.g. ECCO Guideline) and the use of network meta-anaysis.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG IBD Guideline - Methodology]]>
                </itunes:title>
                                    <itunes:episode>4</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Part one of a seven part series discussing different elements of the BSG IBD in Adults Guideline published in June 2025.</p>
<p>Prof. Gordon Moran from the University of Nottingham and Prof. Morris Gordon from the University of Central Lancashire (UCLan) discuss the new BSG IBD Guidelines published in GUT, June 2025. In particular, they discuss insight on methodology used to produce the guideline, the difference in previous guidelines (e.g. ECCO Guideline) and the use of network meta-anaysis.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2200105/c1e-6jovvbo6w65bndo70-z3po3r30u93g-po7k2n.mp3" length="45778944"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Part one of a seven part series discussing different elements of the BSG IBD in Adults Guideline published in June 2025.
Prof. Gordon Moran from the University of Nottingham and Prof. Morris Gordon from the University of Central Lancashire (UCLan) discuss the new BSG IBD Guidelines published in GUT, June 2025. In particular, they discuss insight on methodology used to produce the guideline, the difference in previous guidelines (e.g. ECCO Guideline) and the use of network meta-anaysis.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2200105/c1a-k6400-8domd2dzckdz-5g1ult.png"></itunes:image>
                                                                            <itunes:duration>00:47:41</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[Colorectal Polyps in Patients with Limited Life Expectancy]]>
                </title>
                <pubDate>Fri, 12 Sep 2025 07:55:17 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2139230</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/colorectal-polyps-in-patients-with-limited-life-expectancy</link>
                                <description>
                                            <![CDATA[<p>Dr. Jabed Ahmed and Dr. Ravi Ranjan discuss colorectal polyps in patients with limited life expectancy. The bowel cancer screening strategies rely on the long time a polyp takes before progressing to cancer by early detection and removal of polyps. Although polypectomy comes with risks of some significant complications  the risk is deemed small compared to the benefit of cancer prevention. This risk benefit equation changes in patients with advanced age or multiple co-morbidities </p>
<p>This new <a href="https://www.bsg.org.uk/clinical-resource/management-of-colorectal-polyps-in-patients">BSG ACP guidance</a> developed by a multidisciplinary guidance development group aims to provide a structural framework to support clinicians and the patients in decision making in such situations.</p>
<p>Dr. Ranjan is a Consultant physician and gastroenterologist at University Hospital of North Tees and completeing his MD at Newcastle University. He also coordinated the a BSG/ACPGBI guidance.</p>
<p>Video Interview with Dr. Ahmed and Dr. Ranjan: <a href="https://www.bsg.org.uk/web-education/colorectal-polyps-limited-life-expectancy">Colorectal polyps in patients with limited life expectancy</a></p>
<h3>Chapters</h3>
<ul><li>(00:00:09) - BSG Guidelines on management of colorectal polyps</li><li>(00:01:50) - Polypectomy Guidance for elderly patients</li><li>(00:07:58) - Colorectal cancer: non-invasive investigations and outcomes</li><li>(00:10:55) - Charleston Comorbidity Index</li><li>(00:14:19) - How did you calculate the average annual cancer transition rate for polyp</li><li>(00:18:52) - Polypectomy 14, Risk of cancer and complication</li><li>(00:22:05) - Role specific recommendations for polyp MDT 1</li><li>(00:23:56) - Polypectomy 14, Risk of cancer and adverse events</li><li>(00:26:44) - Clinical guidance on polyp and management</li><li>(00:30:02) - Colonoscopy: New Guidance for polyps</li></ul>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Dr. Jabed Ahmed and Dr. Ravi Ranjan discuss colorectal polyps in patients with limited life expectancy. The bowel cancer screening strategies rely on the long time a polyp takes before progressing to cancer by early detection and removal of polyps. Although polypectomy comes with risks of some significant complications  the risk is deemed small compared to the benefit of cancer prevention. This risk benefit equation changes in patients with advanced age or multiple co-morbidities 
This new BSG ACP guidance developed by a multidisciplinary guidance development group aims to provide a structural framework to support clinicians and the patients in decision making in such situations.
Dr. Ranjan is a Consultant physician and gastroenterologist at University Hospital of North Tees and completeing his MD at Newcastle University. He also coordinated the a BSG/ACPGBI guidance.
Video Interview with Dr. Ahmed and Dr. Ranjan: Colorectal polyps in patients with limited life expectancy]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[Colorectal Polyps in Patients with Limited Life Expectancy]]>
                </itunes:title>
                                    <itunes:episode>3</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Dr. Jabed Ahmed and Dr. Ravi Ranjan discuss colorectal polyps in patients with limited life expectancy. The bowel cancer screening strategies rely on the long time a polyp takes before progressing to cancer by early detection and removal of polyps. Although polypectomy comes with risks of some significant complications  the risk is deemed small compared to the benefit of cancer prevention. This risk benefit equation changes in patients with advanced age or multiple co-morbidities </p>
<p>This new <a href="https://www.bsg.org.uk/clinical-resource/management-of-colorectal-polyps-in-patients">BSG ACP guidance</a> developed by a multidisciplinary guidance development group aims to provide a structural framework to support clinicians and the patients in decision making in such situations.</p>
<p>Dr. Ranjan is a Consultant physician and gastroenterologist at University Hospital of North Tees and completeing his MD at Newcastle University. He also coordinated the a BSG/ACPGBI guidance.</p>
<p>Video Interview with Dr. Ahmed and Dr. Ranjan: <a href="https://www.bsg.org.uk/web-education/colorectal-polyps-limited-life-expectancy">Colorectal polyps in patients with limited life expectancy</a></p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2139230/c1e-x9oqqs9370qan7wv6-6z3ggvr2tz80-ep0vif.mp3" length="30254976"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Dr. Jabed Ahmed and Dr. Ravi Ranjan discuss colorectal polyps in patients with limited life expectancy. The bowel cancer screening strategies rely on the long time a polyp takes before progressing to cancer by early detection and removal of polyps. Although polypectomy comes with risks of some significant complications  the risk is deemed small compared to the benefit of cancer prevention. This risk benefit equation changes in patients with advanced age or multiple co-morbidities 
This new BSG ACP guidance developed by a multidisciplinary guidance development group aims to provide a structural framework to support clinicians and the patients in decision making in such situations.
Dr. Ranjan is a Consultant physician and gastroenterologist at University Hospital of North Tees and completeing his MD at Newcastle University. He also coordinated the a BSG/ACPGBI guidance.
Video Interview with Dr. Ahmed and Dr. Ranjan: Colorectal polyps in patients with limited life expectancy]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2139230/c1a-k6400-8dqzz5nxudrx-xymevb.png"></itunes:image>
                                                                            <itunes:duration>00:31:30</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                                    <podcast:chapters url="https://media-assets.castos.com/chapters/2139230/chapter-data.json"
                        type="application/json" />
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG Sedation Guidelines in Gastrointestinal Endoscopy]]>
                </title>
                <pubDate>Fri, 08 Aug 2025 01:00:00 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2105175</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-sedation-guidelines</link>
                                <description>
                                            <![CDATA[<p>Prof. Reena Sidhu, Consultant Gastroenterologist and Honorary Professor at the University of Sheffield, joins Dr. Jabed Ahmed, Gastroenterology Clinical Research Fellow at Imperial College Healthcare NHS Trust, to discuss the BSG Guidelines on Sedation in Gastrointestinal Endoscopy.</p>
<p>They cover key topics including commonly used sedation drugs, monitoring requirements, and the prevention and management of adverse events. The conversation also explores patient communication, special circumstances such as pregnancy, and the need for improved sedation training for trainees.</p>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Prof. Reena Sidhu, Consultant Gastroenterologist and Honorary Professor at the University of Sheffield, joins Dr. Jabed Ahmed, Gastroenterology Clinical Research Fellow at Imperial College Healthcare NHS Trust, to discuss the BSG Guidelines on Sedation in Gastrointestinal Endoscopy.
They cover key topics including commonly used sedation drugs, monitoring requirements, and the prevention and management of adverse events. The conversation also explores patient communication, special circumstances such as pregnancy, and the need for improved sedation training for trainees.]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG Sedation Guidelines in Gastrointestinal Endoscopy]]>
                </itunes:title>
                                    <itunes:episode>2</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Prof. Reena Sidhu, Consultant Gastroenterologist and Honorary Professor at the University of Sheffield, joins Dr. Jabed Ahmed, Gastroenterology Clinical Research Fellow at Imperial College Healthcare NHS Trust, to discuss the BSG Guidelines on Sedation in Gastrointestinal Endoscopy.</p>
<p>They cover key topics including commonly used sedation drugs, monitoring requirements, and the prevention and management of adverse events. The conversation also explores patient communication, special circumstances such as pregnancy, and the need for improved sedation training for trainees.</p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2105175/c1e-n6nggcd8d0gc9z4gr-jp3kv94qf154-nqiplm.mp3" length="24384768"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Prof. Reena Sidhu, Consultant Gastroenterologist and Honorary Professor at the University of Sheffield, joins Dr. Jabed Ahmed, Gastroenterology Clinical Research Fellow at Imperial College Healthcare NHS Trust, to discuss the BSG Guidelines on Sedation in Gastrointestinal Endoscopy.
They cover key topics including commonly used sedation drugs, monitoring requirements, and the prevention and management of adverse events. The conversation also explores patient communication, special circumstances such as pregnancy, and the need for improved sedation training for trainees.]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2105175/c1a-k6400-9jq2xr3ncd4g-xsg1xz.png"></itunes:image>
                                                                            <itunes:duration>00:25:23</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
                    <item>
                <title>
                    <![CDATA[Introduction to the BSG with President, Prof. Colin Rees]]>
                </title>
                <pubDate>Fri, 11 Jul 2025 08:53:00 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2086151</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/introduction-with-bsg-president-prof-colin-rees</link>
                                <description>
                                            <![CDATA[<p>Prof. Colin Rees and Dr. Roisin Bevan chat about all things BSG. As well as being elected president of the BSG, Colin is a Professor of Gastroenterology at Newcastle University and an Honorary Consultant at South Tyneside and Sunderland NHS Trust. Dr. Roisin Bevan, Chair of the BSG Education Committee, is a consultant physician and gastroenterologist in North Tees and Hartlepool NHS Foundation Trust. </p>
<h3>Chapters</h3>
<ul><li>(00:00:09) - BSG: From Top to Bottom</li><li>(00:01:27) - The BSG</li><li>(00:05:22) - Bsg committees and how to get more involved</li><li>(00:12:21) - The BSG Live Review</li><li>(00:13:54) - BSG Project 90</li><li>(00:20:20) - BSG Podcast</li></ul>]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[Prof. Colin Rees and Dr. Roisin Bevan chat about all things BSG. As well as being elected president of the BSG, Colin is a Professor of Gastroenterology at Newcastle University and an Honorary Consultant at South Tyneside and Sunderland NHS Trust. Dr. Roisin Bevan, Chair of the BSG Education Committee, is a consultant physician and gastroenterologist in North Tees and Hartlepool NHS Foundation Trust. ]]>
                </itunes:subtitle>
                                    <itunes:episodeType>full</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[Introduction to the BSG with President, Prof. Colin Rees]]>
                </itunes:title>
                                    <itunes:episode>1</itunes:episode>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[<p>Prof. Colin Rees and Dr. Roisin Bevan chat about all things BSG. As well as being elected president of the BSG, Colin is a Professor of Gastroenterology at Newcastle University and an Honorary Consultant at South Tyneside and Sunderland NHS Trust. Dr. Roisin Bevan, Chair of the BSG Education Committee, is a consultant physician and gastroenterologist in North Tees and Hartlepool NHS Foundation Trust. </p>]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2086151/c1e-2jn22bmm3pot67j04-9jq02j5qcg4p-7tkbt1.mp3" length="20910336"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[Prof. Colin Rees and Dr. Roisin Bevan chat about all things BSG. As well as being elected president of the BSG, Colin is a Professor of Gastroenterology at Newcastle University and an Honorary Consultant at South Tyneside and Sunderland NHS Trust. Dr. Roisin Bevan, Chair of the BSG Education Committee, is a consultant physician and gastroenterologist in North Tees and Hartlepool NHS Foundation Trust. ]]>
                </itunes:summary>
                                    <itunes:image href="https://episodes.castos.com/6841bf13d4fc03-86689111/images/2086151/c1a-k6400-5zokrzgdipr5-pj8zhp.png"></itunes:image>
                                                                            <itunes:duration>00:21:46</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                                    <podcast:chapters url="https://media-assets.castos.com/chapters/2086151/chapter-data.json"
                        type="application/json" />
                            </item>
                    <item>
                <title>
                    <![CDATA[BSG From Top to Bottom - Trailer]]>
                </title>
                <pubDate>Wed, 18 Jun 2025 09:56:28 +0000</pubDate>
                <dc:creator>British Society of Gastroenterology</dc:creator>
                <guid isPermaLink="true">
                    https://permalink.castos.com/podcast/65381/episode/2069058</guid>
                                    <link>https://bsg-fromtoptobottom.castos.com/episodes/bsg-from-top-to-bottom-trailer</link>
                                <description>
                                            <![CDATA[]]>
                                    </description>
                <itunes:subtitle>
                    <![CDATA[]]>
                </itunes:subtitle>
                                    <itunes:episodeType>trailer</itunes:episodeType>
                                <itunes:title>
                    <![CDATA[BSG From Top to Bottom - Trailer]]>
                </itunes:title>
                                                    <itunes:season>1</itunes:season>
                                <itunes:explicit>false</itunes:explicit>
                <content:encoded>
                    <![CDATA[]]>
                </content:encoded>
                                    <enclosure url="https://episodes.castos.com/6841bf13d4fc03-86689111/2069058/c1e-dpzwwim6x7dcp60qq-25n6o2m0cm1n-brvpx3.mp3" length="887040"
                        type="audio/mpeg">
                    </enclosure>
                                <itunes:summary>
                    <![CDATA[]]>
                </itunes:summary>
                                                                            <itunes:duration>00:00:55</itunes:duration>
                                                    <itunes:author>
                    <![CDATA[British Society of Gastroenterology]]>
                </itunes:author>
                            </item>
            </channel>
</rss>
